Belldegrun Arie Insider Trading
Get the latest insider transactions of Belldegrun Arie. Belldegrun Arie is Director in Talon Therapeutics, Inc. ($EMLR) and Director in Arno Therapeutics, Inc ($ARNI) and Director in Cougar Biotechnology, Inc. ($CGRB) and Chairman, President and CEO in Kite Pharma, Inc. ($KITE) and Director in UroGen Pharma Ltd. ($URGN) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON). Discover the current value of Belldegrun Arie shares.
Address: UCLA SCHOOL OF MEDICINE, 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES 90095-1738CA
Belldegrun Arie is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| EMLR | Talon Therapeutics, Inc. | Director | 0 | 0.00 |
| CGRB | Cougar Biotechnology, Inc. | Director | 64,664 | 0.00 |
| KITE | Kite Pharma, Inc. | Chairman, President and CEO | 159,160 | 8,486,411.20 |
| ARNI | Arno Therapeutics, Inc | Director | 2,262,838 | 181,027.04 |
| ALLO | Allogene Therapeutics, Inc. | 583,034 | ||
| URGN | UroGen Pharma Ltd. | Director | 245,452 | |
| KRON | Kronos Bio, Inc. | Director | 438,703 |
Insider Trading Transactions of Belldegrun Arie
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 24.18 | 20,600 | 498,108 | 20,600 |
| May 25 2021 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Buy | 18.22 | 379,066 | 6,906,583 | 583,034 | |
| May 25 2021 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Option Exercise | 18.22 | 379,066 | 6,906,583 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Buy | 5.00 | 3,241 | 16,205 | 245,452 |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | 5.00 | 3,241 | 16,205 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 182,866 | 0 | 438,703 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 240,872 | 0 | 679,575 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 685,750 | 0 | 685,750 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 1,376,313 | 0 | 2,062,063 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 182,866 | 0 | 438,703 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 16.15 | 253,251 | 4,090,004 | 2,315,314 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 240,872 | 0 | 679,575 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 173,333 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 685,750 | 0 | 685,750 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 228,315 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 0.00 | 1,376,313 | 0 | 2,062,063 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 650,000 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Buy | 16.15 | 253,251 | 4,090,004 | 2,315,314 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 1,304,563 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 173,333 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 228,315 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 650,000 | 0 | 0 |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Option Exercise | 0.00 | 1,304,563 | 0 | 0 |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | 28.24 | 10,000 | 282,400 | 10,000 |
| Jun 04 2020 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Buy | 47.00 | 40,000 | 1,880,000 | 40,000 | |
| Jun 04 2020 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Buy | 47.00 | 106,382 | 4,999,954 | 1,798,163 | |
| Mar 20 2020 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Option Exercise | 18.22 | 379,066 | 6,906,583 | 379,066 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | 34.83 | 10,000 | 348,300 | 10,000 |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | 34.83 | 10,000 | 348,300 | 10,000 |
| May 15 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Sell | 0.00 | 598,935 | 0 | 4,791,480 |
| May 15 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 13,413 | 0 | 515,076 |
| Apr 30 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Sell | 0.00 | 598,937 | 0 | 5,390,415 |
| Apr 30 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 13,413 | 0 | 501,663 |
| Mar 28 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Buy | 4.02 | 128,000 | 514,560 | 212,211 |
| Mar 28 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | 4.02 | 128,000 | 514,560 | 0 |
| Mar 15 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 115,333 | 0 | 150,333 |
| Mar 15 2019 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Option Exercise | 26.89 | 195,133 | 5,247,126 | 195,133 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 18.00 | 35,000 | 630,000 | 35,000 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 142,248 | 0 | 3,710,006 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 5,989,352 | 0 | 5,989,352 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Buy | 0.00 | 1,497,336 | 0 | 1,497,336 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Option Exercise | 0.00 | 27,095 | 0 | 0 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Option Exercise | 0.00 | 1,140,829 | 0 | 0 |
| Oct 17 2018 | ALLO | Allogene Therapeutics, In ... | Belldegrun Arie | Director | Option Exercise | 0.00 | 285,207 | 0 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Buy | 0.00 | 50,000 | 0 | 159,160 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 0.00 | 159,160 | 0 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 180.00 | 1,607,750 | 289,395,000 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 180.00 | 159,329 | 28,679,220 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 180.00 | 430,190 | 77,434,200 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 180.00 | 500,000 | 90,000,000 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 180.00 | 500,000 | 90,000,000 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 51.96 | 95,700 | 4,972,572 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 51.96 | 43,500 | 2,260,260 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 63.87 | 44,057 | 2,813,921 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 63.87 | 56,643 | 3,617,788 | 0 |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 47.42 | 159,700 | 7,572,974 | 0 |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Buy | 0.00 | 50,000 | 0 | 135,507 |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 179.66 | 26,347 | 4,733,605 | 109,160 |
| May 09 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Buy | 68.57 | 17,000 | 1,165,690 | 85,507 |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 0.00 | 66,000 | 0 | 1,607,750 |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Buy | 0.00 | 43,800 | 0 | 68,507 |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 47.72 | 159,700 | 7,620,884 | 159,700 |
| Dec 22 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Sell | 50.86 | 3,493 | 177,654 | 24,707 |
| Aug 17 2016 | ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Buy | 0.00 | 714,285 | 0 | 2,262,838 |
| Aug 17 2016 | ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Option Exercise | 0.44 | 357,142 | 156,250 | 357,142 |
| Apr 11 2016 | ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Option Exercise | 0.37 | 177,256 | 65,585 | 177,256 |
| Jan 14 2016 | ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Buy | 0.35 | 1,448,062 | 506,822 | 1,548,543 |
| Jan 14 2016 | ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Buy | 0.35 | 714,285 | 250,000 | 858,094 |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Buy | 0.00 | 28,200 | 0 | 28,200 |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President a ... | Option Exercise | 63.87 | 100,700 | 6,431,709 | 100,700 |
| Mar 03 2008 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 26.99 | 300 | 8,097 | 59,964 |
| Mar 03 2008 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 27.00 | 4,700 | 126,900 | 64,664 |
| Dec 20 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 30.50 | 15,000 | 457,500 | 59,664 |
| Dec 18 2007 | EMLR | Talon Therapeutics, Inc. | Belldegrun Arie | Director | Option Exercise | 1.12 | 40,000 | 44,800 | 40,000 |
| Jun 19 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 23.90 | 3,700 | 88,430 | 44,664 |
| Jun 13 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Option Exercise | 24.50 | 10,000 | 245,000 | 10,000 |
| May 10 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 21.10 | 7,100 | 149,810 | 40,964 |
| Mar 09 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 18.15 | 4,000 | 72,600 | 22,864 |
| Mar 09 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 18.30 | 4,000 | 73,200 | 26,864 |
| Mar 09 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 18.40 | 5,500 | 101,200 | 32,364 |
| Mar 09 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 18.85 | 500 | 9,425 | 32,864 |
| Mar 09 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 18.55 | 1,000 | 18,550 | 33,864 |
| Jan 10 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Buy | 0.00 | 18,864 | 0 | 18,864 |
| Jan 10 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Option Exercise | 0.39 | 38,411 | 14,999 | 38,411 |
| Jan 10 2007 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Option Exercise | 2.60 | 38,411 | 99,869 | 38,411 |
| Dec 18 2006 | EMLR | Talon Therapeutics, Inc. | Belldegrun Arie | Director | Option Exercise | 6.82 | 40,000 | 272,800 | 40,000 |
| Sep 11 2006 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Option Exercise | 4.50 | 30,000 | 135,000 | 30,000 |
| Sep 11 2006 | CGRB | Cougar Biotechnology, Inc ... | Belldegrun Arie | Director | Option Exercise | 4.50 | 200,000 | 900,000 | 200,000 |
| Nov 15 2005 | EMLR | Talon Therapeutics, Inc. | Belldegrun Arie | Director | Option Exercise | 4.75 | 40,000 | 190,000 | 40,000 |
| Jul 18 2005 | EMLR | Talon Therapeutics, Inc. | Belldegrun Arie | Director | Option Exercise | 1.33 | 20,000 | 26,600 | 20,000 |
| Jul 18 2005 | EMLR | Talon Therapeutics, Inc. | Belldegrun Arie | Director | Option Exercise | 1.65 | 20,000 | 33,000 | 20,000 |